Scinai Immunotherapeutics (SCNI) Other Operating Expenses (2014 - 2024)
Scinai Immunotherapeutics (SCNI) reported Other Operating Expenses of $8.4 million for Q4 2024, down 8.38% on a YoY basis from $9.2 million in Q1 2024, and up 545.33% sequentially from -$1.9 million in Q3 2024.
Scinai Immunotherapeutics (SCNI) Other Operating Expenses (2014 - 2024) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 7 years of Other Operating Expenses data on file, last reported at $8.4 million in Q4 2024.
- For the quarter ending Q4 2024, Other Operating Expenses fell 8.38% year-over-year to $8.4 million; the trailing twelve-month figure through Dec 2025 stood at $8.4 million (up 28.96% YoY), and the FY2025 full-year result was $39000.0, changed N/A from the prior year.
- Other Operating Expenses grew to $8.4 million in Q4 2024, from -$1.9 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $9.2 million in Q4 2023 to a low of -$75.5 million in Q3 2020.
- A 5-year average of -$5.4 million and a median of -$12000.0 in 2021 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses sank 467.26% in 2020 and jumped 31333.33% in 2022, its largest moves.
- Tracing SCNI's Other Operating Expenses over 5 years: stood at -$125000.0 in 2020, then jumped by 90.4% to -$12000.0 in 2021, then jumped by 31333.33% to $3.7 million in 2022, then soared by 144.32% to $9.2 million in 2023, then decreased by 8.38% to $8.4 million in 2024.
- Business Quant data shows SCNI's Other Operating Expenses at $8.4 million in Q4 2024, -$1.9 million in Q3 2024, and $124000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 8.39 Mn |
| Sep 30, 2024 | -1.88 Mn |
| Jun 30, 2024 | 124,000.00 |
| Mar 31, 2024 | -124,000.00 |
| Dec 31, 2023 | 9.16 Mn |
| Sep 30, 2023 | -5.21 Mn |
| Dec 31, 2022 | 3.75 Mn |
| Sep 30, 2022 | -16.94 Mn |
| Jun 30, 2022 | 7.52 Mn |
| Mar 31, 2022 | -6,000.00 |
| Dec 31, 2021 | -12,000.00 |
| Dec 31, 2020 | -125,000.00 |
| Sep 30, 2020 | -75.49 Mn |
| Sep 30, 2019 | -13.31 Mn |
| Dec 31, 2014 | 202,000.00 |